Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3- one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose

Oncology Reports

Volumn 27, Issue 2, 2012, Pages 347-355

  Takemura, Akira ^a   Che, Xiao Fang ^a   Tabuchi, Takafumi ^a   Moriya, Shota ^a   Miyazawa, Keisuke ^a   Tomoda, Akio ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

2 aminophenoxazine 3 one; 2 deoxy D glucose; Hepatocellular carcinoma cells; Normal hepato cellular cells; Pro apoptotic effect

Indexed keywords

2 AMINOPHENOXAZINE 3 ONE; ANTINEOPLASTIC AGENT; DEOXYGLUCOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL DESTRUCTION; CELL COUNT; CELL MEMBRANE DEPOLARIZATION; CELL STRAIN HEPG2; CELL STRUCTURE; CELL VACUOLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL SURVIVAL; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXAZINES; RATS;

EID: 84855718181     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1531     Document Type: Article

References (35)

1. Warburg O: On the origin of cancer cells. Science 24: 309-314, 1956.
2. Pelicano H, Martin DS, Xu RH and Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646, 2006. (Pubitemid 44187614)
3. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MI and Huang P: Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65: 613-621, 2005.
4. Zhang F and An RI: Chemosensitizing and cytotoxic effects of 2-deoxy-D-glucose on breast cancer cells. J Cancer Res Ther 5: S41-S43, 2011.
5. Minakami S and Yoshikawa H: The effect of active cation transport, pH and inorganic phosphate concentration on erythrocyte glycolysis. J Biochem 59: 145-150, 1966.
6. Ui M: A role of phosphofructokinase in pH dependent regulation of glycolysis. Biochim Biophys Acta 124: 310-322, 1966.
7. Maidorn RP, Cragoe EJ and Tannock IF: Therapeutic intracellular pH as a possible mechanism of tumor selective therapy. Br J Cancer 67: 297-303, 1993.
8. Izumi H, Torigoe T, Ishguchi H, Uramoto H, Yoshida Y, Tanabe M, Ise T, Murakmi T, Yoshida T, Nomoto M and Kohno K: Cellular pH regulators: potential promising molecular target for cancer chemotherapy. Cancer Treat Rev 29: 541-549, 2003. (Pubitemid 37428326)
9. Harguindey S, Arranz JL, Wahl ML, Orive G and Reshkin SJ: Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res 29: 2127-2136, 2009.
10. Rich IN, Worthington-White D, Garden OA and Musk P: Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+/H+ exchanger. Blood 95: 1427-1434, 2000. (Pubitemid 30099857)
11. Kim KM and Lee YJ: Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL-mediated apoptosis by amiloride. J Cell Biochem 96: 376-389, 2005. (Pubitemid 41437869)
12. Che XF, Akiyama S and Tomoda A: Suppression of the proliferation of cancer cell lines, KB-3-1 and K562 cells preceded by a decrease in intracellular pH caused by phenoxazine derivatives. Oncol Rep 19: 1253-1258, 2008.
13. Zheng CL, Che XF, Akiyama S, Miyazawa K and Tomoda A: 2-Aminophenoxazine-3-one induces cellular apoptosis by causing rapid intracellular acidification and generating reactive oxygen species in human lung adenocarcinoma cells. Int J Oncol 36: 641-650, 2010.
14. Che XF, Zheng CL, Akiyama S and Tomoda A: 2-Aminophenoxazine-3-one and 2-amino-4,4a-dihydro-4a,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells. Proc Jpn Acad Ser B Phys Biol Sci 87: 199-213, 2011.
15. + exchanger precedes apoptotic events in the MNK45 and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one. Oncol Rep 25: 341-346, 2011.
16. Parniak M and Kalant N: Incorporation of glucose into glycogen in primary cultures of rate hepatocytes. Can J Biochem Cell Biol 63: 333-340, 1985. (Pubitemid 15028699)
17. Maschek G, Savaraj N, Priebe W, Braunshweiger P, Hamilton K, Tidmarsh GF, De Yong IR and Lampidis TI: 2-Deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 64: 31-34, 2004. (Pubitemid 38114078)
18. Singh D, Banerji AK, Dwarakanath BS, Tripathi RP, Gupta JP, Mathew TL, Ravindranath T and Jain V: Optimizing cancer radiotherapy with 2-deoxy-D-glucose. Strahlenther Onkol 181: 507-514, 2005.
19. Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ and Spitz DR: 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 67: 3364-3370, 2007. (Pubitemid 46724876)
20. Sahra IB, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, Marchand-Brustel Y, Giorgetti-Peraldi S, Cormont M, Bertolotto C, Deckert M, Auberger P, Tanti JF and Bost F: Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p3-dependent apoptosis in prostate cancer cells. Cancer Res 70: 2465-2475, 2010.
21. Loar P, Wahl H, Kshirsagar M, Gossner G, Griffith K and Liu JR: Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells. Am J Obstet Gynecol 202: 371.e1-e8., 2010.
22. Zhong D, Xiong L, Liu T, Liu X, Liu X, Chen J, Sn S-Y, Khuri FR, Zong Y, Zhou Q and Zhou W: The glycolytic inhibitor 2-deoxy-glucose activates multiple prosurvival pathways through IGFlR. J Biol Chem 284: 23225-23233, 2009.
23. Shara IB, Tanti JF and Bust F: The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells. Autophagy 6: 670-671, 2010.
24. Schafer DF and Sorrell MF: Hepatocellular carcinoma. Lancet 353: 1253-1257, 1999. (Pubitemid 29168472)
25. Simonetti RG, Liberati A, Angiolini C and Pagliaro L: Treatment of hepatocellular carcinoma: a systemic review of randomized controlled trials. Ann Oncol 8: 117-136, 1997. (Pubitemid 27112878)
26. Nakachi T, Tabuchi T, Takasaki A, Arai S, Miyazawa K and Tomoda A: Anticancer activity of phenoxazines produced by bovine erythrocytes on colon cancer cells. Oncol Rep 23: 1517-1522, 2010.
27. Kawaguchi T, Miyazawa K, Moriya S, Ohtomo T, Che XF, Naito M, Itoh M and Tomoda A: Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress. Int J Oncol 387: 643-654, 2011.
28. Matsuyama S and Reed JC: Mitochondria-dependent apoptosis and cellular pH regulation. Cell Death Differ 7: 1155-1165, 2000. (Pubitemid 32042222)
29. Matsuyama S, Liopis j, Deverqux QL, Tsien RY and Reed JC: Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol 2: 318-325, 2000.
30. Shirato K, Imaizumi K, Abe A and Tomoda A: Phenoxazine derivatives induce caspase-independent cell death in human glioblastoma cell lines, A-172 and U-231 MG. Oncol Rep 17: 201-208, 2007.
31. Takasaki A, Hanyu H, Iwamoto T, Shirato K, Izumi R, Toyota H, Mizuguchi J, Miyazawa K and Tomoda A: Mitochondrial depolarization and apoptosis associated with sustained activation of c-jun-N-terminal kinase in the human multiple myeloma cell line U266 induced by 2-aminophenoxazine-3-one. Mol Med Rep 2: 199-203, 2009.
32. Miyano-Kurosaki N, Ikegami K, Kurosaki K, Endo T, Aoyagi H, Hanami M, Yasumoto J and Tomoda A: Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells. J Pharmacol Sci 110: 87-97, 2009.
33. Miyano-Kurosaki N, Kurosaki K, Hayashi M, Takaku H, Hayafune M, Shirato K, Kasuga T, Endo T and Tomoda A: 2-Aminophenoxazine-3-one suppresses the growth of mouse malignant melanoma B16 cells transplanted into C57BL/6Cr Slc mice. Biol Pharm Bull 29: 2197-2201, 2006. (Pubitemid 44690942)
34. Hongo T, Miyano-Kurosaki N, Kurosaki K, Hata A, Harigae S and Tomoda A: 2-Aminophenoxazine-3-one prevents pulmonary metastasis of mouse B16 melanoma cells in mice. J Pharmacol Sci 114: 63-68, 2010.
35. Tamura J, Tanaka J, Fujita K, Yoshida M, Kasamatsu T, Arii S and Tobe T: Effect of anticancer agents on cell cycle of regenerating hepatocytes in rats. J Surg Res 53: 218-226, 1992.